Blood brain barrier endothelial cells express candidate amyloid precursor protein-cleaving secretases

References

• Selkoe D J. Amyloid β-protein and the genetics of Alzheimer's disease. J Biol Chem 1996; 271: 18295–18298
   PubMed Web of Science ®Google Scholar
• Evin G, Beyreuther K, Masters C. Alzheimer's disease amyloid precursor protein (AßPP): proteolytic processing, secretase and βA4 amyloid production. Amyloid: Inter J Clin Invest 1994; 1: 263–280
   Web of Science ®Google Scholar
• Anderson J P, Esch F S, Keim P S, Sambamurti K, Lieberburg I, Robakis N K. Exact cleavage site of Alzheimer amyloid precursor in neuronal PC-12 cells. Neurosci Lett 1991; 128: 126–129
   PubMed Web of Science ®Google Scholar
• Sisodia S. β-Amyloid precursor protein cleavage by a membrane-bound protease. Proc Natl Acad Sci USA 1994; 89: 6075–6079
   Web of Science ®Google Scholar
• Zhong Z, Higaki J, Murakami K, Wang Y, Catalano R, Quon D, Cordell B. Secretion of β-amyloid precursor protein involves multiple cleavage sites. J Biol Chem 1994; 269: 627–632
   PubMed Web of Science ®Google Scholar
• Citron M, Teplow D, Selkoe D J. Generation of amyloid β protein from its precursor is sequence specific. Neuron 1995; 14: 661–670
   PubMed Web of Science ®Google Scholar
• Papastoitsis G, Siman R, Scott R, Abraham C R. Identification of a metalloprotease from Alzheimer's disease brain able to degrade the β-amyloid precursor protein and generate amyloidogenic fragments. Biochemistry 1994; 33: 192–199
   PubMed Web of Science ®Google Scholar
• Conn K J, Pietropaolo M, Ju S T, Abraham C R. Monoclonal antibodies against the human metalloprotease E.C.3.4.24.15 label neurofibrillq tangles in Alzheimer's disease brain. J Neurochem 1996; 66: 2011–2018
   PubMed Web of Science ®Google Scholar
• Meckelein B, de Silva H, Roses A, Rao P, Pettenati M, Xu P, Hodge R, Glucksman M, Abraham C R. Human endopeptidase E.C.3.4.24.15 is localized on chromosome 19 within the linkage region for late-onset Alzheimer's disease AD2 locus. Genomics 1996; 31: 246–249
   Google Scholar
• Abraham C R, Driscoll J, Potter H, Van Nostrand W E, Tempst P. A calcium-activated protease from Alzheimer's disease brain cleaves at the N-terminus of the amyloid P-protein. Biochem Biophys Res Commun 1991; 174: 790–796
   PubMed Web of Science ®Google Scholar
• Razzaboni B, Papastoitsis G, Koo E, Abraham C R. A calcium stimulated serine protease from monkey brain degrades the P-amyloid precursor protein. Brain Res 1992; 589: 207–211
   Google Scholar
• Mok S S, Evin G, Li Q-X, Smith A I, Beyreuther K, Masters C L, Small D H. A novel metalloprotease in rat brain cleaves the amyloid precursor protein of Alzheimer's disease generating amyloidogenic fragments. Biochemistry 1997; 36: 156–163
   Google Scholar
• Brown A M, Tummolo D M, Spruyt M A, Jacobsen J S, Sonnenberg-Reines J. Evaluation of Cathepsins D and G and EC 3.4.24.15 as candidate P-secretase proteases using peptide and amyloid precursor protein substrates. J Neurochem 1996; 66: 2436–2445
   Google Scholar
• Rubin L L, Hall D, Porter E. S., Barbu K, Cannon C, Horner H C, Janatpour M, Liaw C W, Manning K, Morales J, Tanner L I, Tomaselli K J, Bard F. A cell culture model of the blood brain barrier. J Cell Biol 1991; 115: 1725–1735
   PubMed Web of Science ®Google Scholar
• Van Nostrand W., Davis-Salinas J, Saporito-Irwin S. Amyloid 6-protein induces the cerebrovascular cellular pathology of Alzheimer's disease and related disorders. Ann N Y Acad Sci, USA 1996; 777: 297–302
   PubMed Web of Science ®Google Scholar
• Van Nostrand W, Rozemuller A, Chung R, Cotman C, Saporito-Lrwin S. Amyloid P-protein precursor in cultured leptomeningeal smooth muscle cells. Amyloid: Int Jour Exp Clin Invest 1994; 1: 1–7
   Web of Science ®Google Scholar
• Wells J M, Amaratunga A, McKenna D C, Abraham C R, Fine R E. Amyloid β-protein precursor and apolipoprotein E production in cultured cerebral endothelial cells. Amyloid: Int J Clin Invest 1995; 2: 229–233
   Web of Science ®Google Scholar
• Wisniewski H, Frackowiak J, Zoltowska A, Kim K. Vascular P-amyloid in Alzheimer's disease angiopathy is produced by proliferating and degenerating smooth muscle cells. Amyloid: Int J Exp Clin Invest 1994; 1: 8–16
   Web of Science ®Google Scholar
• Wisniewski H, Wegiel J, Wang K, Lach B. Ultra-structural studies of the cells forming amyloid in the cortical vessel wall in Alzheimer's disease. Acta Neuropathol 1992; 84: 117–127
   PubMed Web of Science ®Google Scholar
• Chen M, Inestrosa N, Ross G, Fernandez H. Platelets are the primary source of amyloid 6-peptide in human blood. Biochem Biophys Res Commun 1995; 213: 96–103
   PubMed Web of Science ®Google Scholar
• Abraham C R, Selkoe D J, Potter H. Apolipoprotein E: a pathologic chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett 1988; 135: 235–238, Immunochemical identification of the serine protease inhibitor a22 Wisniewski T and Frangione B (1992)
   Google Scholar
• Davies T, Long H, McMenamin M, Rathbun W, Seetoo K, Tibbles H, Billingslea A, Sgro K., Fishman J, Levesque C, Smith S, Wells J, Simons E. Activated Alzheimer disease platelets retain more beta-amyloid precursor protein. Neurobiol Aging 1997; 18: 147–153
   PubMed Web of Science ®Google Scholar
• Davies T, Long H, Tibbles H., Wells J, Rathbun W, Seetoo K, McMenamin M, Smith S, Feldman R G, Levesque C, Fine R E, Simons E R. Moderate and advanced Alzheimer's patients exhibit platelet activation differences. Neurobiol Aging 1997; 18: 155–162
   PubMed Web of Science ®Google Scholar
• Buee L, Hof P, Bouras C, Delacourte A, Perl D, Morrison J, Fillit H. Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders. Acta Neuropathol 1994; 87: 469–480
   PubMed Web of Science ®Google Scholar
• Stewart P, Hayakawa K, Akers M, Vinters H. A morphometric study of the blood-brain barrier in Alzheimer's disease. Laboratory Invest 1992; 67: 734–742
   PubMed Web of Science ®Google Scholar
• Davies D, Hardy J. Age and neurodegenerative disease related changes in the blood brain barrier deserve more thorough investigation. Neurobiol Aging 1988; 9: 46–48
   PubMedGoogle Scholar
• Dorheim M, Tracey W, Pollock J, Grammas P. Nitric oxide synthase activity is elevated in brain microvessels in Alzheimer's disease. Biochem Biophys Res Commun 1994; 205: 659–665
   PubMed Web of Science ®Google Scholar
• Tamaoka A, Kalaria R N, Lieberburg I, Selkoe D J. Identification of a stable fragment of the Alzheimer amyloid precursor containing the P-protein in brain microvessels. Proc Natl Acad Sci U.S.A. 1992; 89: 1345–1349
   PubMed Web of Science ®Google Scholar
• Landror U, Wang G, Klein W., Holzman T, Krafft G. Potential PAPPP-processing proteinase activities from Alzheimer's and control brain tissues. J Protein Chem 1994; 13: 357–366
   Google Scholar
• Abraham C R, Razzaboni B L, Papastoitsis G, Picard E, Kanemaru K, Meckelein B, Mucke L. Purification and cloning of brain proteases capable of degrading the β-amyloid precursor protein. Ann N. Y. Acad Sci 1992; 674: 174–179
   PubMed Web of Science ®Google Scholar
• McDermott J R, Biggins J A, Gibson A M. Human brain peptidase activity with the specificity to generate the N-terminus of the Alzheimer p-amyloid protein from its precursor. Biochem Biophys Res Commun 1992; 185: 746–752
   Google Scholar
• Wang G, Landror U, Holzman T, Klein W, Krafft G. Cleavage of fluorogenic substrates for ABPP-process-ing proteases by human brain extracts. Molec Chem Neuropathol 1994; 23: 191–199
   Google Scholar
• Abraham C R, BenMeir A, Tempst P. Facile and sensitive assay for monitoring proteolytic activities with defined specificities: studies on arnyloid β-protein processing in Alzheimer's disease. Peptide Res 1990; 3: 211–215
   Google Scholar
• Davies T A, Fine R E, Johnson R J, Levesque C A, Rathbun W H, Seetoo K F, Smith S J, Strorneier G, Volicer L, Delva L, Simons E R. Non-Age related differences in throm-bin responses by platelets from male patients with advanced Alzheimer's disease. Biochem Biophys Res Commun 1993; 194: 537–543
   PubMed Web of Science ®Google Scholar
• Davies T, Long H, Rathbun W, Sgro K, Tibbles H, Smith S, Seetoo K, McMenamin M, Johnson R, Wells J, Levesque C, Fine R, Simons E. Platelets from patients with Alzheimer's disease or other dementias exhibit disease-specific and apolipoprotein E-correlatable defects. Amyloid: Int J Exp Clin Invest 1996; 3: 13–19
   Web of Science ®Google Scholar
• Zlokovic B, Martel C, Mackic J, Matsubara E, Wisniewski T, McComb G, Frangione B, Ghiso J. Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer's amyloid p. Biochem Biophys Res Commun 1994; 205: 1431–1437
   Google Scholar
• Meckelein B, Marshall D CL, Conn K J, Pietropaolo M, Van Nostrand W E, Abraham C R. Identification of a novel serine protease-like molecule in human brain. Mol Brain Res 1998; 55: 181–197
   Google Scholar
• Davies T A, Billingslea A, Long H, Wells J, Eisenhauer P, Tibbles H., Smith S, Fine R, Simons E. Brain en-dothelial cell secretases cleave retained amyloid precursor protein from Alzheimer disease platelets. J Clin Lab Med 1998, in press
   Google Scholar
• Bush A I, Martins R N, Rumble B, Moir R, Fuller S, Milward E, Currie J, Ames D, Weidemann A, Fischer P, Multhaup G, Beyreuther K, Masters C L. The amyloid precursor protein of Alzheimer's disease is released by human platelets. J Biol Chem 1990; 265: 15977–15983
   PubMed Web of Science ®Google Scholar
• Gardella J E, Ghiso J, Gorgone G A, Marratta D, Kaplan A, Frangione P. B, Gorevic P D. Intact Alzheimer amyloid precursor protein (APP) is present in platelet membranes and is encoded by platelet mRNA. Biochem Siophys Res Commun 1990; 173: 1292–1298
   PubMed Web of Science ®Google Scholar